Summit Medical to collaborate on WISDOM study

Summit Medical Group has announced it will collaborate on the Women Informed to Screen Depending on Measures of Risk (WISDOM) study, the aim of which is to revolutionise breast cancer screening guidelines. The WISDOM study will determine whether a personalized, risk-based screening schedule that takes into consideration genetic and other factors for example breast density and family history, is as safe and effective for women as the current standard of care, namely the annual screening mammograms based on age. Horizon Blue Cross Blue Shield of New Jersey announced earlier this year that it intends to cover the costs for 5,000 of its members to participate in the study. Summit Medical will work to engage female patient who are covered by Horizon.

Dr. Priya Jadeja, a breast surgeon at Summit Medical Group and a WISDOM Study physician liaison, said: “Breast cancer screening guidelines have the potential for more personalized care. For some women, the individual risk of breast cancer is low and screening every other year may be an option. Studies are necessary to both determine women who are low-risk and to ensure that women of high risk are being screened adequately. With the WISDOM Study, we are striving to revolutionize breast cancer screening by determining if a personalized breast cancer screening schedule based on risk-assessment and biology improves detection, while reducing over-diagnosis and false positive readings. Participation in this study can make a big difference to the health and peace of mind of all women now and for generations to come.  That’s very empowering.”